Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lademann

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Wiener Medizinische Wochenschrift (1946)|January 1, 1994
[Complicated malaria tropica--therapy with artemether]G H Boecken, M Lademann
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Antibiotic-associated diarrhea]E C Reisinger, M Lademann, R Krause
MMW Fortschritte Der Medizin|April 24, 2004
[Tick-borne encephalitis (FSME)--how great is the danger really?]M Lademann, B Wild, E C Reisinger
European Journal of Medical Research|September 27, 2000
Schistosomiasis and travel medicineM Lademann, G D Burchard, E C Reisinger
Tropical Medicine & International Health : TM & IH|January 13, 2000
Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISAM Niedrig, M Lademann, P Emmerich, et al.
Deutsche Medizinische Wochenschrift (1946)|May 26, 2005
[Laboratory diagnosis of Pneumocystis pneumonia--new developments]D Riebold, C Fritzsche, M Lademann, et al.
Deutsche Medizinische Wochenschrift (1946)|March 22, 2002
[Histoplasmosis group disease in bat researchers returning from Cuba]K Erkens, M Lademann, K Tintelnot, et al.
The Journal of Infectious Diseases|July 1, 2008
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccineE Tauber, H Kollaritsch, F von Sonnenburg, et al.
European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Wiener Medizinische Wochenschrift (1946)|January 1, 1994
[Complicated malaria tropica--therapy with artemether]G H Boecken, M Lademann
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Antibiotic-associated diarrhea]E C Reisinger, M Lademann, R Krause
MMW Fortschritte Der Medizin|April 24, 2004
[Tick-borne encephalitis (FSME)--how great is the danger really?]M Lademann, B Wild, E C Reisinger
European Journal of Medical Research|September 27, 2000
Schistosomiasis and travel medicineM Lademann, G D Burchard, E C Reisinger
Tropical Medicine & International Health : TM & IH|January 13, 2000
Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISAM Niedrig, M Lademann, P Emmerich, et al.
Deutsche Medizinische Wochenschrift (1946)|May 26, 2005
[Laboratory diagnosis of Pneumocystis pneumonia--new developments]D Riebold, C Fritzsche, M Lademann, et al.
Deutsche Medizinische Wochenschrift (1946)|March 22, 2002
[Histoplasmosis group disease in bat researchers returning from Cuba]K Erkens, M Lademann, K Tintelnot, et al.
The Journal of Infectious Diseases|July 1, 2008
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccineE Tauber, H Kollaritsch, F von Sonnenburg, et al.
European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.
Pageof 1